Farahani, P. “NON-SEVERE HYPOGLYCEMIA RISK DIFFERENCE BETWEEN SULFONYLUREA AND SODIUM-GLUCOSE COTRANSPORTER-2 INHIBITORS (SGLT2-I) AS AN ADD-ON TO METFORMIN IN RANDOMIZED CONTROLLED TRIALS”. Journal of Population Therapeutics and Clinical Pharmacology, vol. 24, no. 2, June 2017, pp. e32-e40, doi:10.22374/1710-6222.24.2.6.